Article Per Year (5 Year)
p-Index From 2021 - 2026
0.659
P-Index
This Author published in this journals
All Journal Bisma : Business and Management Journal Jurnal Sistem Informasi, Akuntansi dan Manajemen Cermin Dunia Kedokteran
Dewi, Putri Purnama
Unknown Affiliation
Decision Sciences, Operations Research & Management Economics, Econometrics & Finance Health Professions Social Sciences

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

 1 
Analisis Rasio dan Penilaian Prestasi pada Perusahaan Tri Banyan Tirta Tbk Periode 2020-2022 Dewi, Putri Purnama; Sianturi, Ria Crisna
BISMA : Business and Management Journal Vol. 2 No. 2 (2024): Bisma : Business and Management Journal
Publisher : CV. Kalimasada Group

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59966/bisma.v2i2.1049

Abstract

A company performance evaluation report is a document used to assess and analyze the operational, financial, and strategic performance of a company over a certain period. This report typically covers various aspects such as sales, profits, productivity, efficiency, and the achievement of company goals. This research aims to determine the financial performance of the company evaluated through financial ratio analysis, which includes liquidity ratios, solvency ratios, profitability ratios, and activity ratios of PT. Tri Banyan Tirta Tbk from 2020 to 2022. The data collection technique is conducted through literature study, which involves searching for information sources related to ratio analysis and literature review on PT Tri Banyan Tirta Tbk. The results of this analysis based on liquidity ratios, viewed from the current ratio and quick ratio, indicate that the company's financial performance is considered poor. Based on solvency ratios, viewed from the debt to assets ratio and debt to equity ratio, the company's financial performance is considered poor. Based on profitability ratios, viewed from the net profit margin, Return on Assets, and Return on Equity, the company's financial performance is considered very poor. The results of this study indicate that the company's financial performance declined during the research period. Therefore, efforts are needed to improve the company's financial performance in implementing business strategies
Hukum dan Etika Bisnis pada Akuntansi, Ekonomi, Keuangan Perusahaan dan Investasi Dewi, Putri Purnama; Purba, Dea Natalia
Jurnal Sistem Informasi, Akuntansi dan Manajemen Vol. 5 No. 1 (2025): SINTAMA: Jurnal Sistem Informasi, Akuntansi, dan Manajemen (Jan, 2025)
Publisher : Asosiasi Dosen Akuntansi Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.54951/sintama.v5i1.865

Abstract

This research discusses the role of law and business ethics in accounting, economics, corporate finance, and investment. In the modern business world, decision-making is not only based on economic and financial factors, but must also consider applicable legal regulations and ethical principles. Business law provides guidelines regarding contracts, consumer protection, and intellectual property rights, while business ethics emphasizes transparency, social responsibility, and fair business practices. Using a qualitative case study method in the manufacturing industry, this research finds that compliance with law and business ethics increases financial transparency, prevents unhealthy business practices, and supports company sustainability. Therefore, the integration of law and ethics in business management is a key factor in creating a competitive and sustainable business environment.
Terapi Kotrimoksazol pada Ensefalitis Toxoplasma dengan Penyakit AIDS: Laporan Kasus Dwi Arshanti, Tyas; Dewi, Putri Purnama
Cermin Dunia Kedokteran Vol 53 No 05 (2026): Kedokteran Umum
Publisher : PT Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v53i05.1767

Abstract

Introduction: Toxoplasma encephalitis (TE) is the most common opportunistic infection affecting the central nervous system in patients with HIV/ AIDS and is associated with high morbidity and mortality. In individuals with HIV, TE tends to be more severe and life-threatening. The first-line therapy for TE is a combination of pyrimethamine and sulfadiazine; however, the limited availability of these drugs in some healthcare settings makes cotrimoxazole a potential alternative to pyrimethamine. Case: A 50-year-old Balinese male, married, was brought to the emergency department with confusion lasting for two days prior to admission. Two weeks earlier, he had experienced headache, weakness, odynophagia, and weight loss of 8 kg within one month. The patient had a history of multiple sexual partners, frequent consumption of raw lawar, and occupational exposure as a pig farm worker. Physical examination revealed white plaques on the tongue and pharynx. Laboratory investigations showed a reactive HIV rapid test with a CD4 count of 11 cells/μL, positive anti-Toxoplasma gondii IgG antibodies, and contrast-enhanced cranial CT scan demonstrating multifocal ring-enhancing lesions in the right and left parietal regions with associated cerebral edema. The patient was diagnosed with stage IV HIV/AIDS, oropharyngeal candidiasis, and toxoplasma encephalitis, and was treated with cotrimoxazole 960 mg every 8 hours. Clinical improvement was observed after 11 days of treatment, and follow-up contrast-enhanced CT scan on day 18 showed radiological improvement with reduced perifocal edema and decreased number of lesions. Discussion: The diagnosis of toxoplasma encephalitis in patients with HIV/AIDS is established based on a combination of clinical manifestations, serological findings, and characteristic radiological features. In situations where pyrimethamine and sulfadiazine are unavailable, cotrimoxazole may serve as an effective alternative therapy. The favorable clinical and radiological responses observed in this case support the use of cotrimoxazole as an alternative treatment option for toxoplasma encephalitis. Conclusion: Cotrimoxazole may serve as an effective alternative therapy for toxoplasma encephalitis in patients with reactive HIV infection, particularly in settings where first-line therapy is unavailable, with favorable clinical and radiological outcomes.
Co-Authors Dwi Arshanti, Tyas Purba, Dea Natalia Sianturi, Ria Crisna